News Room

BOSTON--(BUSINESS WIRE)--The Institute for Healthcare Improvement (IHI) and the DAISY Foundation have announced the recipients of the 2021 DAISY Awards for Extraordinary Nurses in Patient Safety, presented in collaboration with IHI. Christa Bedford-Mu, MSN, RN, CNS, CCRN, C-ELBW, receives the individual award. Co-recipients of the team award include the ICU Nursing Team at Swedish Edmonds hospital and the Faith Community Nurses Team at Emory Saint Joseph’s Hospital.

On Tuesday, the FDA and CDC recommended pausing the administration of the Johnson & Johnson COVID vaccine while the agencies investigate an extremely rare possible side effect. Six women in the U.S. who received the J&J vaccine — all between the ages of 18 and 28 — experienced a blood- clotting disorder called cerebral venous sinus thrombosis in the days after getting their shots, and one has died. It’s not yet clear if the clots were related to the vaccine, though a similar disorder has occurred abroad among some recipients of the AstraZeneca COVID vaccine, which uses the same adenovirus-vector technology as Johnson & Johnson’s. As scientists continue to research the cases to determine if and how they may be related to the shot, U.S. regulators’ sudden decision to pause J&J’s distribution has prompted widespread reaction from across the COVID-expert community. Below is an overview of what they are saying.

India's delayed response in regulatory clearance and government-sponsored acquisitions of the mRNA-based Covid vaccines could mean months of extended wait in the markets.

The US yesterday recommended a "pause" in using the single-dose Johnson & Johnson Covid-19 vaccine to investigate reports of rare but potentially dangerous blood clots, a development that could jeopardise the rollout of vaccines around the world.